skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The structural basis for the functional comparability of factor VIII and the long-acting variant recombinant factor VIII Fc fusion protein

Journal Article · · Journal of Thrombosis and Haemostasis
DOI:https://doi.org/10.1111/jth.13700· OSTI ID:1425419
 [1];  [2];  [3];  [3];  [4];  [1];  [5];  [6];  [6];  [1];  [7];  [8]
  1. Biogen, Cambridge, MA (United States); Bioverativ Therapeutics, Waltham, MA (United States)
  2. Harvard Univ., Cambridge, MA (United States). Dept. of Cell Biology; Arizona State Univ., Mesa, AZ (United States). School of Molecular Sciences and Biodesign Inst.
  3. Biogen, Cambridge, MA (United States)
  4. Biogen, Cambridge. MA (United States); Compass Therpeutics, Cambridge, MA (United States)
  5. Harvard Univ., Cambridge, MA (United States). Dept. of Cell Biology
  6. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Molecular Biophysics and Integrated Bioimaging
  7. Biogen, Cambridge, MA (United States); Rockefeller Univ., New York, NY (United States). Lab. of Molecular Electron Microscopy
  8. Biogen, Cambridge, MA (United States); Codiak BioSciences, Cambridge, MA (United States)

Fusion of the human IgG1 Fc domain to the C-terminal C2 domain of B-domain-deleted (BDD) factor VIII (FVIII) results in the recombinant FVIII Fc (rFVIIIFc) fusion protein, which has a 1.5-fold longer half-life in humans. To assess the structural properties of rFVIIIFc by comparing its constituent FVIII and Fc elements with their respective isolated components, and evaluating their structural independence within rFVIIIFc. rFVIIIFc and its isolated FVIII and Fc components were compared by the use of hydrogen–deuterium exchange mass spectrometry (HDX-MS). The structure of rFVIIIFc was also evaluated by the use of X-ray crystallography, small-angle X-ray scattering (SAXS), and electron microscopy (EM). The degree of steric interference by the appended Fc domain was assessed by EM and surface plasmon resonance (SPR). HDX-MS analysis of rFVIIIFc revealed that fusion caused no structural perturbations in FVIII or Fc. The rFVIIIFc crystal structure showed that the FVIII component is indistinguishable from published BDD FVIII structures. The Fc domain was not observed, indicating high mobility. SAXS analysis was consistent with an ensemble of rigid-body models in which the Fc domain exists in a largely extended orientation relative to FVIII. Binding of Fab fragments of anti-C2 domain antibodies to BDD FVIII was visualized by EM, and the affinities of the corresponding intact antibodies for BDD FVIII and rFVIIIFc were comparable by SPR analysis. Thus, the FVIII and Fc components of rFVIIIFc are structurally indistinguishable from their isolated constituents, and show a high degree of structural independence, consistent with the functional comparability of rFVIIIFc and unmodified FVIII.

Research Organization:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); USDOE Office of Science (SC), Biological and Environmental Research (BER); Eli Lilly and Co., Knoxville, TN (United States); National Institutes of Health (NIH)
Grant/Contract Number:
AC02-05CH11231; AC02‐06CH11357; R01GM105404
OSTI ID:
1425419
Journal Information:
Journal of Thrombosis and Haemostasis, Vol. 15, Issue 6; ISSN 1538-7933
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 7 works
Citation information provided by
Web of Science

References (52)

Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII journal August 2015
A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models journal March 2013
Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation journal December 2007
Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy journal March 1997
Overview of the CCP 4 suite and current developments journal March 2011
Effect of pegylation on pharmaceuticals journal March 2003
Exploring “one-shot” kinetics and small molecule analysis using the ProteOn XPR36 array biosensor journal November 2006
Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein journal January 2013
Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein journal July 2015
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs journal March 2012
Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A journal April 2015
The ribosome at improved resolution: New techniques for merging and orientation refinement in 3D cryo-electron microscopy of biological particles journal March 1994
The tertiary structure and domain organization of coagulation factor VIII journal February 2008
Accurate SAXS Profile Computation and its Assessment by Contrast Variation Experiments journal August 2013
Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A journal July 2015
Negative staining and image classification — powerful tools in modern electron microscopy journal January 2004
Genetic diagnosis of haemophilia and other inherited bleeding disorders journal July 2006
Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment journal July 2010
Application of a novel affinity adsorbent for the capture and purification of recombinant Factor VIII compounds journal November 2009
UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
3D Structural Fluctuation of IgG1 Antibody Revealed by Individual Particle Electron Tomography journal May 2015
Three-dimensional reconstruction from a single-exposure, random conical tilt series applied to the 50S ribosomal subunit of Escherichia coli journal May 1987
Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS) journal July 2009
Validation of macromolecular flexibility in solution by small-angle X-ray scattering (SAXS) journal May 2012
Crystal Structure of Human Factor VIII: Implications for the Formation of the Factor IXa-Factor VIIIa Complex journal April 2008
SPARX, a new environment for Cryo-EM image processing journal January 2007
Low-resolution refinement tools in REFMAC 5 journal March 2012
Implementation and performance of SIBYLS: a dual endstation small-angle X-ray scattering and macromolecular crystallography beamline at the Advanced Light Source journal January 2013
A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management: Comparisons of treatment in hemophilia A management journal February 2012
Iterative Stable Alignment and Clustering of 2D Transmission Electron Microscope Images journal February 2012
Use of TLS parameters to model anisotropic displacements in macromolecular refinement journal January 2001
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A journal January 2014
Features and development of Coot journal March 2010
Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A journal August 2015
Evaluation of the toxicology and pharmacokinetics of recombinant factor VIII Fc fusion protein in animals journal December 2015
REFMAC 5 for the refinement of macromolecular crystal structures journal March 2011
The Utility of Hydrogen/Deuterium Exchange Mass Spectrometry in Biopharmaceutical Comparability Studies journal June 2011
Population pharmacokinetics of recombinant factor VIII Fc fusion protein: Clinical Pharmacology in Drug Development journal October 2014
High-resolution mapping of epitopes on the C2 domain of factor VIII by analysis of point mutants using surface plasmon resonance journal April 2014
Improvements in factor concentrates journal January 2010
The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor journal July 1997
Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry journal August 2015
New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins journal August 2015
Structure and flexibility within proteins as identified through small angle X-ray scattering journal January 2009
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice journal March 2016
Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design journal August 2001
Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels journal October 2014
SPIDER image processing for single-particle reconstruction of biological macromolecules from electron micrographs journal October 2008
Phaser crystallographic software journal July 2007
EMAN: Semiautomated Software for High-Resolution Single-Particle Reconstructions journal December 1999
A Factor VIII Neutralizing Monoclonal Antibody and a Human Inhibitor Alloantibody Recognizing Epitopes in the C2 Domain Inhibit Factor VIII Binding to von Willebrand Factor and to Phosphatidylserine journal March 1993
Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site journal January 2004